Seeking Alpha

Diffusion Pharmaceuticals Sends Letter to Stockholders Highlighting Strength of Board Leadership and Positive Progress in Strategic Review, Cautioning Stockholders Regarding ...

Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process Diffusion received bids from more than 15 companies ...
Nasdaq

Diffusion Pharmaceuticals Sees Significant Progress in its Strategic Review Process

Diffusion Board of Directors Rejects Woefully Inadequate, Unsolicited Offer for the Company by client of Investment Bank LifeSci Capital LifeSci-affiliated Fund Commences Proxy Contest for Control of ...
Nasdaq

Diffusion Board Urges Stockholders To Vote "FOR" Each Of Its Six Nominees For Director

(RTTNews) - Biopharmaceutical company Diffusion Pharmaceuticals Inc. (DFFN) said Monday in a letter to its stockholders that the Company's board of directors continue to take steps to unlock ...
WTEN

Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities

LifeSci Special Opportunities Master Fund Announces Support for Diffusion’s Ongoing, Board-led Strategic Review Process and for Diffusion’s Nominees at 2022 Annual Meeting New Director to be Appointed ...
FierceBiotech

Diffusion may disperse: Biotech's board calls for strategic review of all options, including sale

Diffusion Pharmaceuticals is evaluating its options amid the prolonged bear market, including partnerships, licensing deals, divestiture for some of its tech or even selling off the whole biotech. The ...